Mytos
PrivateLast Round
Series A
Nov 30, 2023
Est. Valuation
$1.71M
Total Funding Raised
$21.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mytos is a biotechnology company that has developed a fully automated platform for human cell manufacturing, designed to serve pharmaceutical and biotechnology businesses.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mytos Comparables
Compare Mytos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Multiply Labs | 88% | |
| Cellular Origins | 86% | |
| Ori Biotech | 84% |
Mytos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 30, 2023 | ||||
| Accelerator | Aug 20, 2018 | ||||
| Seed | Aug 1, 2018 | ||||
| Accelerator | Jun 1, 2018 |
Mytos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathexis | Seed |
| Deep Science Ventures | Seed |
| Acequia Capital | Seed |
| Hoxton Ventures | Seed |
| AiSprouts VC | Seed |
| IQ Capital | Series A |
| Buckley Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 151% MoM, reaching 15.9K.
- Sep 3, 2025
Partnered with Novadip to power next-generation cell therapy trials.
Mytos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mytos's valuation, stock price, and market status.
Is Mytos a public or private company?
Mytos is a private company.
What is the current stock price of Mytos?
Mytos is a private company with no public stock price. No recent secondary market data is available.
How much is Mytos worth (valuation)?
Mytos's valuation is estimated at $1.7M based on funding round data.
Can I buy Mytos stock?
Mytos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mytos's last funding round?
Mytos's most recent funding round was Series A on August 20, 2018.
Who are the main investors in Mytos?
Key investors in Mytos include Buckley Ventures, Y Combinator.
Will Mytos IPO soon?
No public IPO plans have been announced for Mytos.
How can I track Mytos secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mytos's secondary market activity and sign up for updates.